To direct the Secretary of Health and Human Services to carry out a public awareness campaign to increase participation by women in clinical trials that are conducted or supported by the National Institutes of Health, and for other purposes.

Bill 118 hr 10484, also known as the Women in Clinical Trials Awareness Act, aims to address the underrepresentation of women in clinical trials conducted or supported by the National Institutes of Health (NIH). The bill directs the Secretary of Health and Human Services to implement a public awareness campaign to encourage more women to participate in these trials.

The purpose of this legislation is to ensure that women are adequately represented in clinical research, as their participation is crucial for understanding how medical treatments and interventions may affect them differently than men. By increasing the number of women in clinical trials, researchers can gather more comprehensive data and develop more effective and personalized treatments for women's health issues.

The bill does not specify the details of the public awareness campaign, but it is likely to include outreach efforts to educate women about the importance of participating in clinical trials, as well as information on how to find and enroll in trials. The campaign may also address common misconceptions and barriers that prevent women from participating in research studies. Overall, the Women in Clinical Trials Awareness Act seeks to promote gender equity in medical research and improve the quality of healthcare for women. By increasing women's participation in clinical trials, the bill aims to advance scientific knowledge and ultimately improve health outcomes for all individuals.